Related Experiment Videos
The most important issue facing the specialty of allergy and immunology today
1Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan 48202.
The Journal of Allergy and Clinical Immunology
|July 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Revised recommendations from the CSO-HNS taskforce on performance of tracheotomy during the COVID-19 pandemic - what a difference a year makes.
Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale·2021
Thatcher wheat line RL6149 carries Lr64 and a second leaf rust resistance gene on chromosome 1DS.
TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2019
Evaluation of Elite Wheat Germ Plasm for Resistance to Tan Spot.
Plant disease·2019
Mechanistic and Clinical Updates in Chronic Rhinosinusitis: 2023-2025.
The Journal of allergy and clinical immunology·2026
Standardised Human Phenotype Ontology Annotation Enables High Quality Phenotypic Data Capture in a Real-World Common Variable Immunodeficiency Cohort.
The Journal of allergy and clinical immunology·2026
Developments in Mast Cell Research.
The Journal of allergy and clinical immunology·2026
ABACHAI - Safety and efficacy of abatacept (s.c.) in patients with CTLA4 insufficiency or LRBA deficiency, a phase II clinical trial.
The Journal of allergy and clinical immunology·2026
Age-stratified CD19+ B cell reference values in children and adolescents -a systematic review and meta-analysis.
The Journal of allergy and clinical immunology·2026
Exploiting KREC: Time for newborn screening and beyond-proceedings from the First International KREC Consortium Meeting.
The Journal of allergy and clinical immunology·2026
Primary Burkitt Lymphoma of the Maxillary Sinus in an Immunocompetent Adult: A Case Report.
Turkish archives of otorhinolaryngology·2026
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab.
Pediatric blood & cancer·2026